18-Mar-2026
InfuSystem To Present At 38th Annual ROTH Conference
TipRanks (Mon, 16-Mar 5:07 PM ET)
InfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026
Business Wire (Mon, 16-Mar 4:30 PM ET)
InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025
Business Wire (Tue, 24-Feb 6:30 AM ET)
InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Business Wire (Tue, 17-Feb 6:30 AM ET)
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
Infusystems Holdings trades on the AMEX stock market under the symbol INFU.
As of March 18, 2026, INFU stock price declined to $9.62 with 98,606 million shares trading.
INFU has a beta of 1.53, meaning it tends to be more sensitive to market movements. INFU has a correlation of 0.17 to the broad based SPY ETF.
INFU has a market cap of $195.63 million. This is considered a Micro Cap stock.
Last quarter Infusystems Holdings reported $36 million in Revenue and $.10 earnings per share. This fell short of revenue expectation by $-376,200 and exceeded earnings estimates by $.03.
In the last 3 years, INFU traded as high as $11.44 and as low as $4.61.
The top ETF exchange traded funds that INFU belongs to (by Net Assets): VTI, AVUV, VXF, DFAS, DFAT.
INFU has outperformed the market in the last year with a price return of +65.9% while the SPY ETF gained +19.2%. INFU has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +1.1% and +0.2%, respectively, while the SPY returned -1.6% and -3.5%, respectively.
INFU support price is $9.50 and resistance is $10.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INFU shares will trade within this expected range on the day.